Here, the antitumor activity of KAN0439834 was explored in vitro using a panel of eight human pancreatic carcinoma cell lines expressing the phosphorylated full-length ROR1 and EGFR. The gene discussed is ROR1; the disease is exocrine pancreatic carcinoma.